← All diseases
Cancer
Lung cancer (small cell)
Do you want to receive a message when there is new research about Small Cell Lung Cancer (SCLC)? This is possible with an account. Create a free account or log in.
Automatically tracked from PubMed and ClinicalTrials.gov, newest on top. Nothing ever disappears here: what you keep in your favorites remains findable. · RSS feed of this disease · only the strongest evidence
Read in plain language what each study is about? With Premium, above every publication you see one sentence explaining what was studied — and you'll be notified as soon as there is new research about Small cell lung cancer. View what Premium costs.
Publications and studies (3320)
- Review articleiA summary of what is known about a topic, written by experts. Not compiled according to fixed search rules, so the selection of studies may be biased. [Electrolyte disorders in oncological patients]. (2024/07/01) ♡
- Role of circulating microRNAs in non-small cell lung carcinoma. (2024/07/01) ♡
- Berberine synergises with ferroptosis inducer sensitizing NSCLC to ferroptosis in p53-dependent SLC7A11-GPX4 pathway. (2024/07/01) ♡
- Integrative oncology for patients with lung cancer: A prospective pragmatic controlled trial. (2024/07/01) ♡
- Biologically Interpretable Model for Precise Recurrence Prediction of Non-Small Cell Lung Cancer. (2024/07/01) ♡
- Development of a Multiscale Mechanistic Model for Predicting Tumor Response to Anti-miR-155. (2024/07/01) ♡
- Hard example mining in Multi-Instance Learning for Whole-Slide Image Classification. (2024/07/01) ♡
- Knowledge Models for Cancer Clinical Practice Guidelines: Construction, Management, and Usage in Question Answering. (2024/07/01) ♡
- A novel inflammatory nutrient index for predicting survival outcomes in patients with non-small cell lung cancer. (2024/06/30) ♡
- Network pharmacology analysis, molecular docking integrated experimental verification reveal β-sitosterol as the active anti-NSCLC ingredient of Polygonatum cyrtonema Hua by suppression of PI3K/Akt/HIF-1α signaling pathway. (2024/06/28) ♡
- Highly Sensitive 3D Nanoplasmonic-Based Epidermal Growth Factor Receptor Mutation Multiplex Assay Chip for Liquid Biopsy. (2024/06/26) ♡
- Pulmonary function test-related prognostic models in non-small cell lung cancer patients receiving neoadjuvant chemoimmunotherapy. (2024/06/25) ♡
- Fibrinogen-to-albumin ratio (FAR) is the best biomarker for the overall survival of patients with non-small-cell lung cancer. (2024/06/24) ♡
- Circulating tumor DNA kinetics: A future tool for radiation therapy personalization in lung cancer? (2024/06/21) ♡
- Early monitoring of plasma KRAS G12C with digital PCR predicts antitumor response to immunotherapy or sotorasib in advanced NSCLC: A brief report. (2024/06/21) ♡
- Review articleiA summary of what is known about a topic, written by experts. Not compiled according to fixed search rules, so the selection of studies may be biased. A Bayesian network meta-analysis of EGFR-tyrosine kinase inhibitor treatments in patients with EGFR mutation-positive non-small cell lung cancer. (2024/06/21) ♡
- The survival and cost-effectiveness analysis of adjunctive Chinese medicine therapy for patients with non-small cell lung cancer: a nationwide cohort study in Taiwan. (2024/06/20) ♡
- Custom scoring based on ecological topology of gut microbiota associated with cancer immunotherapy outcome. (2024/06/20) ♡
- Values of a novel comprehensive prognostic nutritional index (FIDA) in the prognosis of non-small cell lung cancer. (2024/06/20) ♡
- Value of prognostic nutritional index and controlling nutritional status score for advanced non-small cell lung cancer patients receiving PD-1 inhibitors. (2024/06/15) ♡
- Description of individual patientsiThe story of one or a couple of patients. Informative, but you cannot infer from it whether something works in general. Long-term, 13-year survival after immune cell therapy combined with chemotherapy for extensive-stage small-cell lung cancer: a case report. (2024/06/14) ♡
- Laboratory or animal researchiNo research in humans yet. Promising in a test tube or in mice unfortunately means nothing for patients. Green Seaweed Caulerpa racemosa as a Novel Non-Small Cell Lung Cancer Inhibitor in Overcoming Tyrosine Kinase Inhibitor Resistance: An Analysis Employing Network Pharmacology, Molecular Docking, and In Vitro Research. (2024/06/12) ♡
- Review articleiA summary of what is known about a topic, written by experts. Not compiled according to fixed search rules, so the selection of studies may be biased. Twenty-five years with HER2 targeted therapy. (2024/06/10) ♡
- A stability indicating method development and validation of a rapid and sensitive RP-HPLC method for Nintedanib and its application in quantification of nanostructured lipid carriers. (2024/06/10) ♡
- Two nomograms constructed for predicting the efficacy and prognosis of advanced non‑small cell lung cancer patients treated with anti-PD‑1 inhibitors based on the absolute counts of lymphocyte subsets. (2024/06/04) ♡
- Predictors of Early Hospice or Death in Patients With Inoperable Lung Cancer Treated With Curative Intent. (2024/06/01) ♡
- Review articleiA summary of what is known about a topic, written by experts. Not compiled according to fixed search rules, so the selection of studies may be biased. Pathologic Response Evaluation in Neoadjuvant-Treated Lung Cancer. (2024/06/01) ♡
- Review articleiA summary of what is known about a topic, written by experts. Not compiled according to fixed search rules, so the selection of studies may be biased. Microsatellite Instability, Mismatch Repair, and Tumor Mutation Burden in Lung Cancer. (2024/06/01) ♡
- Molecular Testing in Lung Cancer: Recommendations and Update. (2024/06/01) ♡
- Applications of Artificial Intelligence in Lung Pathology. (2024/06/01) ♡
- Accumulation of antitumor polyketides by fermentation of Rubus delavayi Franch. with Clonostachys rogersoniana. (2024/06/01) ♡
- Ailanthone inhibits non-small cell lung cancer growth and metastasis through targeting UPF1/GAS5/ULK1 signaling pathway. (2024/06/01) ♡
- Identifying Anti-NSCLC Bioactive Compounds in Scutellaria via 2D NMR-Based Metabolomic Analysis of Pharmacologically Classified Crude Extracts. (2024/06/01) ♡
- Study on pharmacokinetics and tissue distribution of deoxypodophyllotoxin and its metabolites in tumour-bearing mice. (2024/06/01) ♡
- [Chemical constituents from Clitocybe clavipes and their antitumor activities]. (2024/06/01) ♡
- Multimodal prehabilitation in patients with non-small cell lung cancer: a feasibility study. (2024/05/31) ♡
- Blood-based DNA methylation markers for lung cancer prediction. (2024/05/30) ♡
- Predicting the mechanism of action of YQYYJD prescription in the treatment of non-small cell lung cancer using transcriptomics analysis. (2024/05/23) ♡
- Clinical trialiResearch in patients, without randomization between groups. Useful, but less certain than a randomized trial. Potential mechanism of Chai Gui Zexie Decoction for NSCLC treatment assessed using network pharmacology, bioinformatics, and molecular docking: An observational study. (2024/05/17) ♡
- Efficacy of Shenglin decoction in preventing acute severe lymphocytopenia in patients with non-small cell lung cancer undergoing concurrent chemoradiotherapy: a study protocol for a randomized controlled trial. (2024/05/08) ♡
- p53 activation enhances the sensitivity of non-small cell lung cancer to the combination of SH003 and docetaxel by inhibiting de novo pyrimidine synthesis. (2024/05/04) ♡
- Review articleiA summary of what is known about a topic, written by experts. Not compiled according to fixed search rules, so the selection of studies may be biased. To Crush or Not to Crush: Administering Dabrafenib and Trametinib Through a Nasogastric Tube in a Critically Ill Patient With Nonsmall Cell Lung Cancer - A Case Report and Review of Literature of Targeted Therapies Given Through Enteral Feeding Tubes. (2024/05/01) ♡
- Transitioning to Neoadjuvant Therapy for Resectable Non-Small Cell Lung Cancer: Trends and Surgical Outcomes in a Regionalized Pulmonary Oncology Network. (2024/05/01) ♡
- Review articleiA summary of what is known about a topic, written by experts. Not compiled according to fixed search rules, so the selection of studies may be biased. Deciphering the molecular mechanistic paths describing the chemotherapeutic potential and epigenetic regulation of curcumin in lung cancer: a mini review. (2024/05/01) ♡
- QiDongNing induces lung cancer cell apoptosis via triggering P53/DRP1-mediated mitochondrial fission. (2024/05/01) ♡
- Integrating single-cell and multi-omic approaches reveals Euphorbiae Humifusae Herba-dependent mitochondrial dysfunction in non-small-cell lung cancer. (2024/05/01) ♡
- Review articleiA summary of what is known about a topic, written by experts. Not compiled according to fixed search rules, so the selection of studies may be biased. Review Article: Postoperative Radiotherapy in Resected Non-Small Cell Lung Cancer: Current Status and Enduring Challenges in 2024. (2024/05/01) ♡
- Synthesis of Flavonols and Assessment of Their Biological Activity as Anticancer Agents. (2024/04/28) ♡
- Systematic reviewiAll research on one question is searched according to fixed rules and compared side by side, so that no studies with poor outcomes are missed. Efficacy and safety of different immunotherapies combined with chemotherapy as first-line therapy in patients with small cell lung cancer: a network meta-analysis. (2024/04/17) ♡
- Review articleiA summary of what is known about a topic, written by experts. Not compiled according to fixed search rules, so the selection of studies may be biased. Potential application mechanism of traditional Chinese medicine in treating immune checkpoint inhibitor-induced colitis. (2024/04/10) ♡
codex.care does not provide medical advice. Always discuss symptoms, medication, and treatment choices with your own healthcare provider.